3National Kidney Fundation. KDOQI Clinical Practice Guide- lines and Clinial Practice Recommendations for Diabetes and Chronic Kidney Disease [J]. Am J Kidney Dis, 2007, 49 (SUPPL 2) :$12-S154. 被引量：1
6Karmtej S,Christopher CM,Eric G. IgA deficiency and autoimmu- nity:Review article[J]. Autoimmunity Reviews,2014,13(2) :163 - 177. 被引量：1
7Richard AL. Immunoglobul in a nephropathy: Insights and pro- gress[J]. Translational Research, 2014,163(1) :3 - 7. 被引量：1
8Scan JB,Heather NR. Risk stratification of patients with IgA ne- phropathy review article[J]. American Journal of Kidney Disea ses,2012,59(6) :865 - 873. 被引量：1
9Chrysoula P, Konstantinos P, Nikos P, et al. Hemolytic - uremic syndrome,malignant hypertension and IgA nephropathy: Success- ful treatment with plasma exchange therapy[J]. Transfusion and Apheresis Science,2012,47(2) : 155 - 158. 被引量：1
10Lv JC,Shi SF,Xu DM,et al. Evaluation of the Oxford classifica tion of IgA nephropathy:A systematic review and meta - analysis [J]. American Journal of Kidney Diseases, 2013,62(5) : 891 - 899. 被引量：1
